These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months. Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384 [TBL] [Abstract][Full Text] [Related]
47. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths]. Böttiger M; Heller L; Kamensky P; Svanberg B Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083 [No Abstract] [Full Text] [Related]
48. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay. Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822 [TBL] [Abstract][Full Text] [Related]
50. Measles immunity after revaccination: results in children vaccinated before 10 months of age. Linnemann CC; Dine MS; Roselle GA; Askey PA Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289 [TBL] [Abstract][Full Text] [Related]
51. Immunization against measles (rubeola). Riley HD J Okla State Med Assoc; 1969 Mar; 62(3):107-10. PubMed ID: 5813179 [No Abstract] [Full Text] [Related]
52. Measles control: so near and yet so far. Mitchell CD; Balfour HH Prog Med Virol; 1985; 31():1-42. PubMed ID: 3881804 [No Abstract] [Full Text] [Related]
54. Absence of transmission of the D9 measles virus in the region of the Americas, November 2002 - May 2003. Epidemiol Bull; 2003 Mar; 24(1):24. PubMed ID: 15112620 [No Abstract] [Full Text] [Related]
55. Measles immunity in Israeli young adults: effects of second immunization at 18 years of age. Olsha M; Mendelson E; Shohat T; Cohen D; Duvdevani P; Lerman Y; Danon YL Isr J Med Sci; 1994 Aug; 30(8):596-9. PubMed ID: 8045739 [TBL] [Abstract][Full Text] [Related]
56. Measles eradication in Arkansas. J Ark Med Soc; 1968 Jun; 65(1):63-4. PubMed ID: 4231802 [No Abstract] [Full Text] [Related]
57. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans. Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789 [TBL] [Abstract][Full Text] [Related]